Literature DB >> 10760565

Differential regulation of constitutive and retinoic acid-induced galectin-1 gene transcription in murine embryonal carcinoma and myoblastic cells.

Y Lu1, D Lotan, R Lotan.   

Abstract

Galectin-1 (gal-1), a galactoside-binding lectin, is found in many vertebrate tissues and its expression is regulated during development. We had found that gal-1 expression is increased in F9 murine embryonal carcinoma cells concurrently with induction of differentiation by all-trans retinoic acid (RA). In contrast, gal-1 expression was constitutively high in murine myoblastic C2C12 cells. Therefore, we used these two cell types as models to begin to understand the mechanisms underlying constitutive and RA-induced gal-1 expression. We transfected transiently into F9 cells a series of reporter constructs containing different deletions of the 5' upstream region of the gal-1 gene promoter placed upstream of the chloramphenicol acetyltransferase reporter cDNA and evaluated the activation of transcription by RA treatment. The results indicate that the induction of gal-1 by RA is regulated at least partially at the level of transcription. A strong RA responsiveness region was found within the sequence from -1578 to -1448 upstream of the transcription start site (+1). In contrast, the high constitutive gal-1 expression in C2C12 cells appeared to be mediated by a sequence within the promoter region from -62 to +1, which contains an Sp1 consensus sequence. A gel electrophoretic mobility shift assay indicated that the transcription factor SP1 bound to the gal-1 Sp1 site and mutagenesis of this Sp1 site abolished both the binding of nuclear proteins to the mutated Sp1 site and the high constitutive expression of the gal-1 gene. The results demonstrate that gal-1 expression is cell type-specific and suggest that different factors regulate constitutive and RA-induced gal-1 expression.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10760565     DOI: 10.1016/s0167-4781(00)00055-5

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  7 in total

Review 1.  Galectin genes: regulation of expression.

Authors:  Lorenzo Chiariotti; Paola Salvatore; Rodolfo Frunzio; Carmelo B Bruni
Journal:  Glycoconj J       Date:  2002       Impact factor: 2.916

2.  O-GlcNAcylation and Regulation of Galectin-3 in Extraembryonic Endoderm Differentiation.

Authors:  Mohamed I Gatie; Danielle M Spice; Amritpal Garha; Adam McTague; Mariam Ahmer; Alexander V Timoshenko; Gregory M Kelly
Journal:  Biomolecules       Date:  2022-04-22

3.  Adenoviral-mediated pHyde gene transfer and cisplatin additively inhibit human prostate cancer growth by enhancing apoptosis.

Authors:  Yi Lu; Xiongwen Zhang; Ben Beheshti; Jun Zhang
Journal:  Prostate       Date:  2009-02-15       Impact factor: 4.104

4.  Regulation of adult hematopoietic stem cells fate for enhanced tissue-specific repair.

Authors:  Nilanjana Sengupta; Sergio Caballero; Sean M Sullivan; Lung-Ji Chang; Aqeela Afzal; Sergio Li Calzi; Jennifer L Kielczewski; Sabrina Prabarakan; E Ann Ellis; Leni Moldovan; Nicanor I Moldovan; Michael E Boulton; Maria B Grant; Edward W Scott; Jeffrey R Harris
Journal:  Mol Ther       Date:  2009-07-07       Impact factor: 11.454

5.  Proteomes and signalling pathways of antler stem cells.

Authors:  Chunyi Li; Anne Harper; Jonathan Puddick; Wenying Wang; Chris McMahon
Journal:  PLoS One       Date:  2012-01-18       Impact factor: 3.240

Review 6.  Galectin-1 as a potential cancer target.

Authors:  G A Rabinovich
Journal:  Br J Cancer       Date:  2005-04-11       Impact factor: 7.640

7.  LYAR promotes colorectal cancer cell mobility by activating galectin-1 expression.

Authors:  Yupeng Wu; Ming Liu; Zhuchen Li; Xiao-Bin Wu; Ying Wang; Yadong Wang; Min Nie; Feifei Huang; Junyi Ju; Chi Ma; Renxiang Tan; Ke Zen; Chen-Yu Zhang; Keqin Fu; Yu-Gen Chen; Ming-Rong Wang; Quan Zhao
Journal:  Oncotarget       Date:  2015-10-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.